Research programme 1
Ferumoxtran MRI — Seeing What Conventional Imaging Misses
Ferumoxtran-enhanced MRI uses ultrasmall iron oxide nanoparticles to reveal macrophage-associated biological information beyond what conventional anatomical imaging can show.
By exploiting the uptake of nanoparticles by macrophages, this technology can help identify small lymph node metastases and provide insights into disease processes involving inflammation and immune cells.
Following decades of research, ferumoxtran MRI has progressed into advanced clinical development.